Guidance

ARSAC notes for guidance: good clinical practice in nuclear medicine

Guidance on licencing and best use of radiopharmaceuticals and sealed radioactive sources in diagnosis, treatment or research.

From:
Administration of Radioactive Substances Advisory Committee
Published
17 April 2014
Last updated
1431 JulyMarch 20262025 — See all updates

Documents

Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources

Ref: GOV-21373

PDF, 893557 KB, 8786 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email arsac@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This guidance to good clinical practice for nuclear medicine in the UK is the advice of the Administration of Radioactive Substances Advisory Committee (ARSAC).

The JulyFebruary 20262025 version contains notable updates from the previous version, which areis explained on page 6.1.

Updates to this page

Published 17 April 2014
Last updated 1431 JulyMarch 20262025 href="#full-history">—+ Showshow all updates

  1. Added new version of notes for guidance.

Sign up for emails or print this page